More than 80 companies currently claim to offer manufacturing related services, at different scales of operations, for a variety of oligonucleotide-based products, claims Roots Analysis
Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge.
To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this link
The USD 5.8 billion (by 2030) financial opportunity within the oligonucleotide synthesis, modification and purification services market has been analyzed across the following segments:
- Type of manufacturing
- Custom manufacturing
- Large-scale manufacturing
- Type of Oligonucleotides manufactured
- Antisense Oligonucleotides
- miRNAs
- shRNAs
- siRNAs
- Other Oligonucleotides
- Scale of operation
- Clinical
- Commercial
- Purpose of production
- In-house
- Outsourced
- Target therapeutic area
- Autoimmune Disorders
- Cardiovascular Disorders
- Genetic Disorders
- Infectious Diseases
- Metabolic Disorders
- Neuromuscular Disorders
- Oncological Disorders
- Ophthalmic Disorders
- Other Therapeutic Areas
- Size of manufacturer
- Small
- Mid-sized
- Large
- Key Geographical Region
- North America
- Europe
- Asia-Pacific and Rest of the World
The Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030 report features the following companies, which we identified to be key players in this domain:
- Agilent Technologies
- Ajinomoto Bio-Pharma Services
- BioSpring
- CordenPharma
- Integrated DNA Technologies
- Kaneka Eurogentec
- LGC Biosearch Technologies
- Microsynth
- Nitto Denko Avecia
- Sigma Aldrich
- Thermo Fisher Scientific
- Trilink Biotechnologies
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape: Oligonucleotide Manufacturers (Research and Diagnostic Applications)
5. Market Landscape: Oligonucleotide Manufacturers (Therapeutic Applications)
6. Company Competitiveness Analysis: Oligonucleotide Manufacturers (Research and Diagnostic Applications)
7. Company Competitiveness Analysis: Oligonucleotide Manufacturers (Therapeutic Applications)
8. Company Profiles: Oligonucleotide Manufacturers (Research and Diagnostic Applications)
9. Company Profiles: Oligonucleotide Manufacturers (Therapeutic Applications)
10. Partnerships and Collaborations
11. Recent Expansions
12. Clinical Trial Analysis
13. Capacity Analysis
14. Demand Analysis
15. Market Sizing and Opportunity Analysis
16. Swot Analysis
17. Survey Analysis
18. Executive Insights
19. Concluding Remarks
20. Appendix 1: Tabulated Data
21. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415